Tech Awards: Principia Partners

Risk exposure tracking

Structured finance vendor Principia has enhanced its software by integrating risk exposure tracking for ABS, MBS and CDO investments. This provides a standardised way to monitor compliance and gain a consistent view of risk exposure at the deal or portfolio level. It includes a standard interface to define and capture collateral performance data to consistently manage the underlying behaviour of these securities.

The new software allows users to analyse and manage cashflows and information from the initial deal, through ongoing risk surveillance, compliance, investor reporting and accounting. Risk limits can be set and monitored at any portfolio stratification. Structured finance exposure monitoring is integrated into an enterprise-wide financial reporting and accounting framework.

The technology allows clients to manage and monitor all assets and their associated liabilities and hedges on a single platform. Principia hopes this will reduce the time and resources clients need to allocate to administration and interpreting performance information from multiple data providers and proprietary credit analysis. It should also eliminate the inefficiencies and operational risks associated with spreadsheet proliferation, helping streamline integration with treasury management systems, custodians or trustees.

Standard performance metrics make it possible to drill down into structured finance assets to analyse portfolios at the deal, tranche, collateral and credit enhancement level. Users also benefit from the ability to assess how portfolios perform under stressed scenarios, for example changing default or prepayment rates.

Principia is headquartered in New York, with a European office in London, and a technology centre in Conshohocken, Pennsylvania. Its platform has been in use for 15 years, and won a Technology Innovation Award in 2008.

Only users who have a paid subscription or are part of a corporate subscription are able to print or copy content.

To access these options, along with all other subscription benefits, please contact or view our subscription options here:

You are currently unable to copy this content. Please contact to find out more.

You need to sign in to use this feature. If you don’t have a account, please register for a trial.

Sign in
You are currently on corporate access.

To use this feature you will need an individual account. If you have one already please sign in.

Sign in.

Alternatively you can request an individual account here